DCF — ALLINA HEALTH FARIBAULT MEDICAL CTR
Enterprise Value: $-106.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-106.8M
Enterprise Value
$-33.4M
PV of Cash Flows
$-73.4M
PV of Terminal Value
$-118.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $55.2M | $-6.9M | -12.0% | $-9.2M | $-8.4M |
| Year 2 | $56.9M | $-6.5M | -11.0% | $-8.9M | $-7.4M |
| Year 3 | $58.6M | $-6.1M | -10.0% | $-8.6M | $-6.5M |
| Year 4 | $60.3M | $-6.0M | -10.0% | $-8.5M | $-5.8M |
| Year 5 | $62.1M | $-6.0M | -10.0% | $-8.6M | $-5.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-106.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$53.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12934165559650027
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5